Systematic review suggests CV generics clinically equivalent Clinical study 02 February 2013 Pages: 16 - 16
Further evidence of rituximab benefit in CLL to be presented Media release 02 February 2013 Pages: 17 - 17
Methylnaltrexone bromide gets things moving in constipation Media release 02 February 2013 Pages: 17 - 17
Naproxcinod hits the nail on the head in osteoarthritis Media release 02 February 2013 Pages: 17 - 17
Study targets drugs most in need of research for off-label use Media release 02 February 2013 Pages: 19 - 19
Telithromycin link to hepatotoxicity suggested by DMAs Clinical study 02 February 2013 Pages: 19 - 19
Prenatal fluoxetine exposure may be associated with CV anomalies Clinical study 02 February 2013 Pages: 20 - 20
Actavis gains approval for generic bupropion ER 150mg tablets. Media release 02 February 2013 Pages: 21 - 21
Beclometasone formulation granted orphan drug status in Australia Media release 02 February 2013 Pages: 21 - 21
COX-2 inhibitors still increase BP: updated meta-analysis Clinical study 02 February 2013 Pages: 21 - 21
Varenicline: numerous psychiatric ADRs reported in Australia News item 02 February 2013 Pages: 21 - 21
Generic version of Wellbutrin XL [bupropion] approved by US FDA Media release 02 February 2013 Pages: 22 - 22
Supplemental new drug application for duloxetine withdrawn. Media release 02 February 2013 Pages: 22 - 22
Tetrabenazine available in US for HD-associated chorea. Media release 02 February 2013 Pages: 22 - 22
US FDA approves synthetic conjugated estrogens - a vaginal cream. Media release 02 February 2013 Pages: 22 - 22